The FDA on 1st May 2012 approved Elelyso (taliglucerase alfa) from Pfizer for long-term enzyme replacement therapy to treat a...
Sanofi and its subsidiary Genzyme, announced the publication of results from the ENGAGE registration study evaluating Cerdelga (eliglustat) in treatment-naïve...
Sanofi and its subsidiary Genzyme announced that the European Commission (EC) has granted marketing authorization for Cerdelga (eliglustat) capsules, a...